Bayer Inc v Fresenius Kabi Canada Ltd

Counsel to Fresenius in successfully defending a NOC proceeding relating to patents over AVELOX I.V.™ (moxifloxacin hydrochloride). On a preliminary motion, Fresenius successfully struck the portion of the proceeding relating to a formulation patent. (Prior to joining Lenczner Slaght)